Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022

SELL
$83.14 - $145.99 $208,930 - $366,872
-2,513 Closed
0 $0
Q1 2022

May 04, 2022

SELL
$110.08 - $142.92 $207,280 - $269,118
-1,883 Reduced 42.83%
2,513 $298,000
Q4 2021

Feb 14, 2022

SELL
$99.73 - $148.48 $30,716 - $45,731
-308 Reduced 6.55%
4,396 $606,000
Q3 2021

Nov 08, 2021

BUY
$98.85 - $138.91 $464,990 - $653,432
4,704 New
4,704 $654,000

Others Institutions Holding BHVN

About Biohaven Pharmaceutical Holding Co Ltd.


  • Ticker BHVN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,645,000
  • Market Cap $2.6B
  • Description
  • Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...
More about BHVN
Track This Portfolio

Track Clari Vest Asset Management LLC Portfolio

Follow Clari Vest Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clari Vest Asset Management LLC with notifications on news.